G Cabett Cipolli1, M Sanches Yassuda, I Aprahamian. 1. Ivan Aprahamian, MD, MS, PhD, FACP. Group of Investigation on Multimorbidity and Mental Health in Aging (GIMMA), Internal Medicine Department, Faculty of Medicine of Jundiaí, Jundiaí, Brazil. 250 Francisco Telles street. ZIP 13.202-550. E-mail: ivan.aprahamian@gmail.com.
Abstract
BACKGROUND AND OBJECTIVES: There is little evidence in the literature about the possible relationship between sarcopenia and cognition in older adults. Our objective was to investigate the association between cognitive impairment and sarcopenia in older adults living in the community through a systematic review of published studies. RESEARCH DESIGN AND METHODS: We performed a systematic review with meta-analysis through Pubmed, LILACS, Scielo and Web of Science databases between March 1, 2001 and December 18, 2018. We included longitudinal and cross-sectional studies that evaluated sarcopenia and cognition as a primary objective. RESULTS: Of the 274 studies identified by the systematic review, 10 were included in qualitative analysis (total of 9,703 participants), and 6 were eligible for the meta-analysis (n = 7,045). Mean prevalence of sarcopenia was 10.5%. Cognitive impairment was observed in 269 participants with sarcopenia (40%), compared with 1,616 in non-sarcopenic participants (25.3%). Sarcopenia was significantly associated with cognitive impairment (pooled OR = 2.50, 95% CI = 1.26-4.92; p = 0.008). Heterogeneity across the studies was high and significant (I² = 84%). Discussion and Implications: Our analyzes confirmed that sarcopenic older adults presented a higher prevalence of cognitive impairment. Sarcopenia may represent a risk factor for cognitive decline, but longitudinal studies are needed to explore causality.
BACKGROUND AND OBJECTIVES: There is little evidence in the literature about the possible relationship between sarcopenia and cognition in older adults. Our objective was to investigate the association between cognitive impairment and sarcopenia in older adults living in the community through a systematic review of published studies. RESEARCH DESIGN AND METHODS: We performed a systematic review with meta-analysis through Pubmed, LILACS, Scielo and Web of Science databases between March 1, 2001 and December 18, 2018. We included longitudinal and cross-sectional studies that evaluated sarcopenia and cognition as a primary objective. RESULTS: Of the 274 studies identified by the systematic review, 10 were included in qualitative analysis (total of 9,703 participants), and 6 were eligible for the meta-analysis (n = 7,045). Mean prevalence of sarcopenia was 10.5%. Cognitive impairment was observed in 269 participants with sarcopenia (40%), compared with 1,616 in non-sarcopenicparticipants (25.3%). Sarcopenia was significantly associated with cognitive impairment (pooled OR = 2.50, 95% CI = 1.26-4.92; p = 0.008). Heterogeneity across the studies was high and significant (I² = 84%). Discussion and Implications: Our analyzes confirmed that sarcopenic older adults presented a higher prevalence of cognitive impairment. Sarcopenia may represent a risk factor for cognitive decline, but longitudinal studies are needed to explore causality.
Authors: Kirk I Erickson; Michelle W Voss; Ruchika Shaurya Prakash; Chandramallika Basak; Amanda Szabo; Laura Chaddock; Jennifer S Kim; Susie Heo; Heloisa Alves; Siobhan M White; Thomas R Wojcicki; Emily Mailey; Victoria J Vieira; Stephen A Martin; Brandt D Pence; Jeffrey A Woods; Edward McAuley; Arthur F Kramer Journal: Proc Natl Acad Sci U S A Date: 2011-01-31 Impact factor: 11.205
Authors: Ana Alfaro-Acha; Soham Al Snih; Mukaila A Raji; Yong-Fang Kuo; Kyriakos S Markides; Kenneth J Ottenbacher Journal: J Gerontol A Biol Sci Med Sci Date: 2006-08 Impact factor: 6.053
Authors: P S van Dam; A Aleman; W R de Vries; J B Deijen; E A van der Veen; E H de Haan; H P Koppeschaar Journal: Growth Horm IGF Res Date: 2000-04 Impact factor: 2.372
Authors: Ana Alfaro-Acha; Soham Al Snih; Mukaila A Raji; Kyriakos S Markides; Kenneth J Ottenbacher Journal: J Am Geriatr Soc Date: 2007-02 Impact factor: 5.562
Authors: Alfonso J Cruz-Jentoft; Jean Pierre Baeyens; Jürgen M Bauer; Yves Boirie; Tommy Cederholm; Francesco Landi; Finbarr C Martin; Jean-Pierre Michel; Yves Rolland; Stéphane M Schneider; Eva Topinková; Maurits Vandewoude; Mauro Zamboni Journal: Age Ageing Date: 2010-04-13 Impact factor: 10.668
Authors: Jennifer S Brach; Shannon FitzGerald; Anne B Newman; Sheryl Kelsey; Lewis Kuller; Jessie M VanSwearingen; Andrea M Kriska Journal: Arch Intern Med Date: 2003-11-24
Authors: K Ramoo; Noran N Hairi; A Yahya; W Y Choo; F Mohd Hairi; D Peramalah; S Kandiben; A Bulgiba; Z Mohd Ali; I Abdul Razak; N Ismail; N S Ahmad Journal: Int J Environ Res Public Health Date: 2022-04-14 Impact factor: 4.614
Authors: Hsi-Hsien Chou; Te-Jen Lai; Chi-Hua Yen; Po-Sheng Chang; Ji-Cyun Pan; Ping-Ting Lin Journal: Int J Environ Res Public Health Date: 2022-02-22 Impact factor: 3.390